Bioproduction A3P & MabDesign
Introduction
On June 2–3, 2026, A3P and MabDesign will host the Bioproduction Forum — a key meeting point for professionals driving the development and industrialization of biopharmaceuticals.
The two-day event will feature 12 expert talks, 24 exhibitor booths, and 4 partners, creating a dynamic environment for insightful exchanges, innovation sharing, and practical case-study.
This edition will spotlight mAbs, ADCs, and biosimilars, addressing the full spectrum of challenges shaping today’s bioproduction landscape. Attendees will have the opportunity to delve into regulatory updates — including changes related to ICH Q1 (stability), ICH Q3E (E&L), and USP standards — while exploring new levers for developability: template optimization, AI-driven approaches, strategies to analyze and reduce project failures, and ways to enhance global competitiveness.
Formulation of biological products will also have a central role, with dedicated presentations and discussions on best practices and innovative strategies. In line with the A3P & MabDesign spirit, the Forum is designed to foster concrete knowledge-sharing and meaningful interactions across industry players, start-ups, technology providers, and service organizations.
Join us in Lausanne for two immersive days at the heart of bioproduction.